Results 161 to 170 of about 25,328 (236)

Cumulative cefepime exposure in cancer patients is associated with an increased risk of ertapenem non-susceptible, meropenem susceptible Enterobacterales bacteremia. [PDF]

Microbiol Spectr
Stabler AV, Shropshire WC, Young A, Feng C, Hwang H, Shelburne SA, Vuong NN, Borjan J.   +7 more
europepmc   +1 more source

Clinically Significant Carbapenemases in Gram-Negative Pathogens: Molecular Diversity and Advances in β-Lactamase Inhibitor Therapy. [PDF]

Antibiotics (Basel)
Grossman JM, Thompson DK.
europepmc   +1 more source

High prevalence of bla_NDM gene among a series of carbapenem-resistant Enterobacterales isolates from children less than one year old in Niger. [PDF]

BMC Microbiol
Massir IN, Abdourahamane Y, Ounoussa T, Oumou H, Abdoulaye O, Ousmane A, Harouna M, Souleymane B, Doutchi M, Saidou M, Laminou IM.   +10 more
europepmc   +1 more source

Nacubactam: a review on mechanistic insights and therapeutic promise for combating β-lactam resistance among multidrug-resistant Gram-negative pathogens. [PDF]

Ann Med Surg (Lond)
Kumar D, Kaur N, Surender, Aman S, Bibi A.   +4 more
europepmc   +1 more source

A multicenter performance evaluation of aztreonam-avibactam gradient diffusion susceptibility testing for <i>Enterobacterales</i>. [PDF]

J Clin Microbiol
Bui TI, Csiki-Fejer E, Prudhomme S, Bossy L, Hardy DJ, Wootton M, Zambardi G, Yarbrough ML.   +7 more
europepmc   +1 more source

Clinical outcomes of carbapenem therapy in OXA-48-producing Enterobacterales infections: a French multicentre cohort, systematic review, and meta-analysis. [PDF]

Emerg Microbes Infect
Dortet L, Moreau C, Dinh A, Bonnin RA, Escaut L, Seguret M, Weber L, Figueiredo S, Pilmis B.   +8 more
europepmc   +1 more source

Klebsiella pneumoniae Carbapenemase-Producing Enterobacterales Infection and Colonization in a Long-Term Care Facility - Ontario, Canada, May 2024-January 2025. [PDF]

MMWR Morb Mortal Wkly Rep
Aloosh M, Saeed HM, Mataseje LF.
europepmc   +1 more source

<i>In vitro</i> activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in Japan. [PDF]

JAC Antimicrob Resist
Yanagihara K, Tateda K, Doi Y, Takahashi S, Ohge H, Itahashi K, Okade H, Mikamo H.   +7 more
europepmc   +1 more source

Carbapenemen-resistant Enterobacterales: An issue of global concern

Revista Argentina de Microbiología
openaire   +2 more sources